Clinical Trials Browser

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma, Central Nervous System Neoplasms

NCT07439172 2026-02-27

PRC

Phase 2 Not yet recruiting

70 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioblastoma, Glioma, Oligodendroglioma

NCT07424092 2026-02-20

PED-DNX2401

Phase 2 Not yet recruiting

39 enrolled

CNS

Ependymoma, Glioma, Recurrence

NCT07206849 2025-10-29

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

Phase 2 Not yet recruiting

79 enrolled

CNS

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Glioma

NCT06804655 2025-10-02

EViDENCE-BT

Phase 2 Not yet recruiting

40 enrolled

CNS

Ependymoma, Glioblastoma, Glioma, Medulloblastoma, Meningioma, Neoplasms, Neurologic Manifestations

NCT07120984 2025-08-13

IMAGLIO

Phase 2 Not yet recruiting

52 enrolled

CNS

Glioma

NCT06678867 2025-03-27

P5A

Phase 2 Not yet recruiting

80 enrolled

CNS

Brain Neoplasms, Ependymoma, Glioma

NCT05366062 2022-05-13

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab

Phase 2 Not yet recruiting

28 enrolled

CNS

Glioma

Clinical Trials

Inflammation in Primary and Secondary Malignancies of the Central Nervous System Using [C-11]-CS1P1

PRC

PED-DNX2401

Study of Tovorafenib in High-Grade Glioma and Diffuse Intrinsic Pontine Glioma (DIPG)

EViDENCE-BT

IMAGLIO

P5A

ERC1671 to Treat Malignant Gliomas When Given in Combination With GM-CSF, Cyclophosphamide, Bevacizumab and Pembrolizumab